The 5 most recent market catalysts affecting $SI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 8, 2026
Corporate Catalyst
Neutral
Impact 65
Shoulder Innovations Enters Into A Settlement Agreement With Catalyst Orthoscience To Resolve All Outstanding Patent Litigation Between The Two Companies
Shoulder Innovations announced a settlement agreement with Catalyst OrthoScience, ending all patent litigation between the two. This is a positive development for SI as it removes …
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Buy on Shoulder Innovations, Raises Price Target to $28
UBS analyst Patrick Wood maintained a 'Buy' rating on Shoulder Innovations and raised the price target from $27 to $28. This action signals continued positive sentiment from a majo…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Piper Sandler Reiterates Overweight on Shoulder Innovations, Raises Price Target to $25
Piper Sandler, a prominent investment bank, reiterated its 'Overweight' rating on Shoulder Innovations (SI) and significantly raised its price target from $19 to $25. This analyst …
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $26
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on Shoulder Innovations and raised the price target from $24 to $26. This action signals increased confidence from a prominent…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
Shoulder Innovations Raises FY2026 Sales Guidance from $65.000M-$68.000M to $67.000M-$69.000M vs $67.283M Est
Shoulder Innovations (SI) has filed an 8-K to announce an upward revision to its FY2026 sales guidance. The new range of $67.000M-$69.000M is higher than the previous $65.000M-$68.…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.